QNASL
These highlights do not include all the information needed to use QNASL Nasal Aerosol safely and effectively. See full prescribing information for QNASL Nasal Aerosol.QNASL (beclomethasone dipropionate) Nasal AerosolFor Intranasal Use OnlyInitial U.S. Approval: 1976
Approved
Approval ID
4b8d8e84-b5d2-4e56-97ec-4f72971465c5
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Sep 27, 2022
Manufacturers
FDA
Teva Respiratory, LLC
DUNS: 176697907
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Beclomethasone Dipropionate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code59310-406
Application NumberNDA202813
Product Classification
M
Marketing Category
C73594
G
Generic Name
Beclomethasone Dipropionate
Product Specifications
Route of AdministrationNASAL
Effective DateSeptember 27, 2022
FDA Product Classification
INGREDIENTS (3)
NORFLURANEInactive
Code: DH9E53K1Y8
Classification: IACT
BECLOMETHASONE DIPROPIONATEActive
Quantity: 40 ug in 1 1
Code: 5B307S63B2
Classification: ACTIB
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
Beclomethasone dipropionate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code59310-410
Application NumberNDA202813
Product Classification
M
Marketing Category
C73594
G
Generic Name
Beclomethasone dipropionate
Product Specifications
Route of AdministrationNASAL
Effective DateSeptember 27, 2022
FDA Product Classification
INGREDIENTS (3)
BECLOMETHASONE DIPROPIONATEActive
Quantity: 80 ug in 1 1
Code: 5B307S63B2
Classification: ACTIB
NORFLURANEInactive
Code: DH9E53K1Y8
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT